tag: EMA ×57
European Medicines Agency (relocated from London to Amsterdam in 2019)


Are you a quality manager for a small medical device start-up looking to expand into global markets? Or maybe you are a seasoned device manufacturer preparing to once again traverse quality regulations to deliver a new product to the European market?
Criminals selling counterfeit drugs prey on the vulnerable. The threat of no deal may make anxious patients turn to them.
Dr Philippa Whitford, MP and eminent breast cancer surgeon, shares her concerns for the future of our NHS following Brexit. Recorded in front of a live audience at Arran High School Theatre on Friday 13th September 2019.
Experts warn that European Medicines Agency membership would have had advantages.
Helmuth Porschen ponders the fate of UKCA and wonders why the government can’t persuade the rest of the world to adopt British standards.
BREXIT is causing “damage across the board” to UK science, including missing out on more than £1 billion in funding, campaigners have warned.
As of December 2022, UK companies importing medicines from the EU may need to set up new batch testing facilities. What will this mean for the industry and how did the situation come about?
And it will cost more here because of the UK pulling out of the European Medicines Agency on 30 December.
The coronavirus should remind us of just why international cooperation is so important in reducing the threat of infectious disease.
There are growing post-Brexit differences between which medicines are approved for use in Northern Ireland and the rest of the UK, research from a health think tank indicates.
Brexit could have major implications for health and social care in England. Here we look at some of the latest developments that could have an impact.
US, European, Japanese and Chinese patients could get novel medicines ahead of patients in the UK after Brexit, the CEO of French pharma Ipsen has said in an interview.
Relocation to Amsterdam will give better access to European markets ‘regardless of Brexit outcome’.
A coronavirus vaccine could be ready for approval in a year’s time in an “optimistic scenario”, the European Medicines Agency has said.
More than three quarters of the public think the UK should participate in EU schemes to secure vital protective equipment, as it emerged ministers passed on three opportunities to take part.
Europe’s medicines regulator has said it is temporarily cutting services as it will lose at least 30% of its staff as it relocates to Amsterdam during Brexit.
The European Medicines Agency (EMA) will physically relocate to the Netherlands in early March 2019.
Dutch officials handed over a pair of clogs and the keys to the European Medicines Agency’s temporary base in Amsterdam on Wednesday as the watchdog prepares to leave London after Brexit.
The European Union's medicines' agency has started shifting its work from London to Amsterdam, in a concrete consequence of the looming Brexit.
Bloc plans to bulk-buy key drugs for all 27 countries, potentially leaving Britain ‘behind in the queue’. / “Europe is securing access to key drugs and vaccines as a single region, with huge influence and buying power. As a result of Brexit the UK is now isolated from this system, so our drug supplies could be at risk in the future,” said Dr Andrew Hill, an expert on the pharmaceutical trade.
The European Medicines Agency (EMA) is a European Union agency for the evaluation and supervision of medicinal products.
[BrexitDB NOTE: These agencies have now left the UK.] Wrangle around European Medicines Agency and European Banking Authority after Brussels insists they must leave UK.
As the EU referendum grows ever closer, Lord Darzi, Elias Mossialos and colleagues seek to redress a lack of evidence on the role of the union on our health system.
In the political realm, no one knows how Brexit’s long-running theater of the absurd will end. But for much of the business world, Britain’s departure from the European Union has effectively happened.
Trade unions and regulatory experts warn that budget and staff cuts may lead to drug approval delays or the UK regulator simply rubber-stamping EMA decisions.
Education secretary lauds vaccine rollout saying scientists in UK better than in France, Belgium or US.
NICE has a global reputation as a pioneering HTA – but is that influence at risk now that the UK has left the EU? Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage.
David Davis claims medicine and banking bodies will not have to leave Canary Wharf.
An organisation which represents medicines wholesalers says supplying Northern Ireland remains "challenging, problematic and inefficient".
There are a number of measures that the UK Government must take in order to address the challenges of leaving the EU's single market.
Preparing Brexit: How ready is the UK? is our second report examining government and business preparations for the end of the transition period, building on Preparing Brexit: The scale of the task left for UK government and business, published in July.
The headlong rush to an end nobody voted for, and why No Deal is a man-made asteroid strike. ... Linguistic programming as Johnson drills the buzzphrase “undemocratic backstop” into the national mind. ... Ingrid – our secret agent within the Tory Party – finally succumbs to Stockholm Syndrome. The Government’s snappy 1,400 page No Deal for small businesses.
The hot rhetoric of ‘taking back control’ of our borders is being replaced by cold reality.
"If you will do this damn silly thing, don't do it in this damn silly way. This bill will come back to haunt this gov't, in the same way so many other mistakes, harrumphed to the rafters in this House, have."
The government and its supporters are beginning to claim 'benefits' of being outside the European Union some of which were always available to EU member states or, in other cases, are not benefits at all.
The divorce from the EU looks set to be delayed and could be softened or even abandoned, but the cost of separation is already apparent.
Britain must work with other countries to prevent friction on medicine rules post-Brexit to avoid being sidelined by the global drug industry, according to a report from the U.K.’s biggest pharmaceutical lobby group.
As obvious as it is to see the decline in the number of clinical trials in the UK, the reasons behind this trend are as complicated to ascertain. Fiona Maini, Principal - Global Compliance and Strategy at Medidata Solutions, thinks the issue is multifaced with Brexit playing a part in this.
Health Secretary Matt Hancock has claimed Brexit allowed the UK to approve a Covid vaccine more quickly than other European Union (EU) countries.
Everyone is fishing in the same pond. Stocks built up in readiness for Brexit are having to be replenished. If another pandemic strikes, we’ll hardly be in the best position to get through it.
The European Medicines Agency or EMA ensures that the medicines in the European Union are effective and safe. Find out what EMA is in a nutshell and how it protects patients.


◈ myth ×3
◈ news ×32
◈ tweet ×1
◈ video ×4
◈ wiki ×1

related tags

◈ MHRA ×21
◈ health ×10
◈ NHS ×9
◈ NI ×8